BIOUX
Price
$67.55
Change
-$1.29 (-1.87%)
Updated
Jun 17 closing price
Net Assets
2.17B
GFAFX
Price
$85.47
Change
-$0.91 (-1.05%)
Updated
Jun 17 closing price
Net Assets
360.63B
Interact to see
Advertisement

BIOUX vs GFAFX

BIOUX vs GFAFX Comparison Chart in %
View a ticker or compare two or three
VS
BIOUX vs. GFAFX commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOUX is a Hold and GFAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 361B vs. BIOUX (2.17B). GFAFX pays higher dividends than BIOUX: GFAFX (0.20) vs BIOUX (0.00). BIOUX was incepted earlier than GFAFX: BIOUX (10 years) vs GFAFX (25 years). BIOUX (1.04) is less costly to investors than GFAFX (0.65). GFAFX is a more actively managed with annual turnover of: 32.00 vs. BIOUX (30.00). GFAFX has a lower initial minimum investment than BIOUX: GFAFX (250) vs BIOUX (5000000). BIOUX annual gain was more profitable for investors over the last year : 29.04 vs. GFAFX (11.44). BIOUX return over 5 years is better than : 47.07 vs. GFAFX (20.74).
BIOUXGFAFXBIOUX / GFAFX
Total Expense Ratio1.040.65160%
Annual Report Gross Expense Ratio1.040.65160%
Fund Existence10 years25 years-
Gain YTD16.0658.490189%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B361B1%
Annual Yield % from dividends0.000.20-
Returns for 1 year29.0411.44254%
Returns for 3 years96.8246.22209%
Returns for 5 years47.0720.74227%
Returns for 10 yearsN/A113.38-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEWCX103.23N/A
N/A
American Funds New World C
IHOSX25.40N/A
N/A
Hartford International Opportunities R4
GTMRX19.17N/A
N/A
Goldman Sachs Small/Mid Cap Growth R
IUAIX35.95N/A
N/A
VY® Invesco Equity and Income I
AZBCX25.26N/A
N/A
Virtus Small-Cap C